Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
종목 코드 VVOS
회사 이름Vivos Therapeutics Inc
상장일Dec 11, 2020
CEOHuntsman (R. Kirk)
직원 수109
유형Ordinary Share
회계 연도 종료Dec 11
주소7921 Southpark Plaza,
도시LITTLETON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호80120
전화18669084867
웹사이트https://vivos.com/
종목 코드 VVOS
상장일Dec 11, 2020
CEOHuntsman (R. Kirk)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음